Fallbericht
Atopic Dermatitis Flare Following Initiation of Nemolizumab
Journal of Drugs in Dermatology · 2026
DOI: 10.36849/jdd.9249 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Olivia M Burke und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Eczema, Dyshidrotic. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Dermatitis, AtopicAntibodies, Monoclonal, HumanizedEczema, DyshidroticHumansMaleMiddle AgedSymptom Flare UpTreatment Outcome
Substanzen
Antibodies, Monoclonal, Humanizednemolizumab
Zitieren
APA
Burke, O. M., Beer, J., & Elman, S. A. (2026). Atopic Dermatitis Flare Following Initiation of Nemolizumab. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9249
Vancouver
Burke OM, Beer J, Elman SA. Atopic Dermatitis Flare Following Initiation of Nemolizumab. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.9249
BibTeX
@article{Burke2026,
author = {Burke, Olivia M and Beer, Jacob and Elman, Scott A},
title = {Atopic Dermatitis Flare Following Initiation of Nemolizumab},
journal = {Journal of Drugs in Dermatology},
year = {2026},
doi = {10.36849/jdd.9249}
}
EUVIMED